DrugPatentWatch Database Preview
KOVANAZE Drug Profile
» See Plans and Pricing
When do Kovanaze patents expire, and what generic alternatives are available?
Kovanaze is a drug marketed by St Renatus and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-three patent family members in thirteen countries.
The generic ingredient in KOVANAZE is oxymetazoline hydrochloride; tetracaine hydrochloride. There are three drug master file entries for this compound. Additional details are available on the oxymetazoline hydrochloride; tetracaine hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Kovanaze
Indicators of Generic Entry
Summary for KOVANAZE
International Patents: | 23 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 1 |
Clinical Trials: | 4 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for KOVANAZE |
What excipients (inactive ingredients) are in KOVANAZE? | KOVANAZE excipients list |
DailyMed Link: | KOVANAZE at DailyMed |


Recent Clinical Trials for KOVANAZE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Virginia Commonwealth University | Phase 2 |
University of North Carolina, Chapel Hill | Phase 4 |
US Patents and Regulatory Information for KOVANAZE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
St Renatus | KOVANAZE | oxymetazoline hydrochloride; tetracaine hydrochloride | SPRAY, METERED;NASAL | 208032-001 | Jun 29, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
St Renatus | KOVANAZE | oxymetazoline hydrochloride; tetracaine hydrochloride | SPRAY, METERED;NASAL | 208032-001 | Jun 29, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
St Renatus | KOVANAZE | oxymetazoline hydrochloride; tetracaine hydrochloride | SPRAY, METERED;NASAL | 208032-001 | Jun 29, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KOVANAZE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
St Renatus | KOVANAZE | oxymetazoline hydrochloride; tetracaine hydrochloride | SPRAY, METERED;NASAL | 208032-001 | Jun 29, 2016 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for KOVANAZE
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | PI1010303 | Start Trial |
South Korea | 20170026639 | Start Trial |
Eurasian Patent Organization | 024184 | Start Trial |
New Zealand | 595376 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |